HEPTROMIC, a new approach to Hepatocellular Carcinoma

HEPTROMIC is the first research network funded by the European Commission devoted to the study of Hepatocellular Carcinoma (HCC). It is a 3-year translational research project which aims to solve core problems in the management of HCC, the third most common cause of cancer-related death worldwide. The partners taking part in this initiative have met today in Barcelona in the called kick-off meeting, which officially starts the project. Dr. Josep Maria Llovet, ICREA Research professor at IDIBAPS - Hospital Clínic, and his team lead that project which is meant to change the treatment of this cancer in the next years.

The meeting started with an institutional presentation where Dr. Joan Albert Barberà, Research Associate Director of IDIBAPS, introduced the institution that leads the project. Among other participants, Mr. Albert Moreno, European Union Secretary of the Catalan Government, and Dr. Toni Dedeu, Director of the Catalan Heath Ministry of International Relations and Cooperation Office, did a presentation of the research in Catalonia and its growing importance in the European research. After the scientific meeting to discuss all the Work Packages of the project, Prof. Jessica Zucman-Rossi, Head of Inserm unit U674, Génomique Fonctionnelle des tumeurs solides, offered a scientific presentation about “Identification of drivers through sequencing in cancer”.

By defining biomarkers for identification of HCC patients with poor-prognosis and novel genetic or epigenetic drivers, HEPTROMIC will achieve the breakthroughs that are critical for developing more personalized therapeutic approaches. Findings obtained from human tissue samples by applying state-of-the-art technology will be confirmed in sophisticated experimental models and translated into novel biomarkers and targets for high impact clinical use.

HEPTROMIC’s core team comprises leading European and American researchers in the basic, translational and clinical fields of liver cancer. Its aim is to lay down a foundation for a sustainable network of expertise based on complex, system level, translational research approaches in liver cancer and closely related disease areas. The project is willing to open up revolutionary new research horizons in liver cancer over the next decade.

The fight against Hepatocellular Carcinoma is the challenge… HEPTROMIC is the answer.

For further information: www.heptromic.eu

HEPTROMIC partners